Innokon Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.40 M
- Paid Up Capital ₹ 1.40 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -77.24%
- Profit Growth -212.88%
- Ebitda -161.44%
- Net Worth -72.24%
- Total Assets -17.05%
About Innokon Laboratories
Innokon Laboratories Private Limited (ILPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 December 2008 and has a history of 16 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.40 M and a paid-up capital of Rs 1.40 M, as per Ministry of Corporate Affairs (MCA) records.
Ramanatha Pillai, Arumuga Pillai, Sathiyapaul Jeyagopal, and Three other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73200MH2008PTC188806
-
Company No.
188806
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Dec 2008
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Innokon Laboratories Private Limited offer?
Innokon Laboratories Private Limited offers a wide range of products and services, including Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Innokon Laboratories?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanatha Pillai
|
Additional Director | 12-May-2018 | Current |
|
Arumuga Pillai
|
Additional Director | 12-May-2018 | Current |
|
Sathiyapaul Jeyagopal
|
Additional Director | 12-May-2018 | Current |
|
Ganesh Monian
|
Director | 11-Dec-2008 | Current |
|
Nantheeswaran Kumar
|
Director | 11-Dec-2008 | Current |
|
Arumugaperumal Pillai
|
Director | 23-Feb-2011 | Current |
Financial Performance of Innokon Laboratories.
Innokon Laboratories Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 77.24% decrease. The company also saw a substantial fall in profitability, with a 212.88% decrease in profit. The company's net worth observed a substantial decline by a decrease of 72.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innokon Laboratories?
In 2019, Innokon Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innokon Laboratories?
Innokon Laboratories has a workforce of 4 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innokon Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innokon Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
